knowledge -WSS

knowledge

author：comprehensive 2025-09-28 01:38:17 - browse：54158

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： STAT's guide to the next generation of CAR

focus

WSS

Readout Newsletter: The latest on Novavax, Merck, Bluebird

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

#NeedHerScience: shining a light on gender disparities in medicine

Readout Newsletter: The latest on Novavax, Merck, Bluebird

What would happen to your eyes if you looked at the solar eclipse?

focus

knowledge

Wikipedia

Supreme Court strikes down use of affirmative action

Venture capital firm's plans to take over Akron hospital face hurdles

State Dept. review finds Biden bears some blame for Afghanistan failures

Venture capital firm's plans to take over Akron hospital face hurdles

At least 13 dead in Texas as scorching temps continue

Medicare drug price negotiation legal challenge met with skepticism

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

CDC concerned about possible undetected monkeypox spread in U.K.

Duchenne breakthrough therapy leaves behind pioneering families

In areas with more Black doctors, Black people live longer

focus

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Health Care Service Corp to buy Cigna Medicare Advantage plans

Death of patient in Alzheimer’s trial raises question of possible risks

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

CDC concerned about possible undetected monkeypox spread in U.K.

hotspot

focus

focus

hotspot